
Chemical Biologist, Assistant Professor at the Hebrew University of Jerusalem, @hujimed. Postdoc in @disney_lab and Ph.D in @michafridman lab
Jerusalem, Israel
Joined July 2015
- Tweets286
- Following438
- Followers301
- Likes2.1K
Raphael Isaac Benhamou retweeted
Development of PROTAC-Based Strategies for Cannabinoid Receptor Type 1 (CB1R) Degradation in Cancer | ACS Pharmacology & Translational Science pubs.acs.org/doi/10.1021/acs…
Raphael Isaac Benhamou retweeted
RNA structures are important too! In our latest Technology Feature, Michael Eisenstein explores how researchers are utilizing a growing toolbox of techniques to understand how RNA 3D structures inform their biological function.
nature.com/articles/s41592-0…
Raphael Isaac Benhamou retweeted
New in J. Med. Chem RiboTACs degrades LGALS1 mRNA by 97%, inducing apoptosis and blocking invasion in cancer models. Potency driven by linker + RNase L recruiter optimization PAL & NanoBRET confirm live-cell RNase L engagement pubs.acs.org/doi/10.1021/acs… pubs.acs.org/doi/10.1021/acs…
Raphael Isaac Benhamou retweeted
Noah built a platform to discover covalent small molecules that react with RNA. Many protein-reactive warheads also react with RNA. We then Converted a DNA binder into a rna covalent compound.
Preprint: biorxiv.org/content/10.1101/…
#RNA #CovalentDrugs #ChemicalBiology #DrugDiscovery
Raphael Isaac Benhamou retweeted
Advancing target validation with PROTAC technology: Expert Opinion on Drug Discovery tandfonline.com/doi/full/10.…
Raphael Isaac Benhamou retweeted
🚨We're Hiring! The School of Pharmacy seeks candidates for a tenure-track faculty position in Medicinal Chemistry! Please apply no later than August 31st, 2025
Apply now: ttp.ekmd.huji.ac.il/Pages/de…
#Hiring #MedicinalChemistry #AcademicJobs #Pharmacy #HUJI
Raphael Isaac Benhamou retweeted
Big thanks to Derek Lowe for the thoughtful commentary on our manuscript! Your insights on antifungal research and the challenges we face in drug discovery are invaluable.
What the Antifungals Are Really Doing | Science | AAAS science.org/content/blog-pos…
Raphael Isaac Benhamou retweeted
Our latest RSC Chem Bio review explores RNA-targeted small molecule libraries—their evolution, design principles, and drug discovery potential.
We also highlight key challenges, like the need for better datasets for AI-driven RNA therapeutics.
pubs.rsc.org/en/content/arti…
Raphael Isaac Benhamou retweeted
RNA: From Biology to Drug Discovery symposium, April 14-15, 2025, at UF Scripps. Speakers include: Darnell , Maquat, Rinn, Krainer, Krichevsky, and more!
Register wertheim.scripps.ufl.edu/dep…
#RNA #DrugDiscovery #Biology #UF #Scripps
Raphael Isaac Benhamou retweeted
We are very excited by this first disclosure of our large collaboration with the lab of Nikhil Munshi @DanaFarber using a cMYC mRNA degrader to affect Multiple Myeloma. ASH Annual Meeting
sciencedirect.com/science/ar…
Raphael Isaac Benhamou retweeted
Our focus issue on RNA biology features reviews that explore the many faces of #RNA, diving into the processes mediating the lifecycle of RNA, the regulatory roles of RNA, the importance of RNA in disease, and the technologies used to study RNA. cell.com/molecular-cell/issu…
Raphael Isaac Benhamou retweeted
Congratulations, Yuquan (Hamish) Tong. We ID RNAs bound by small molecules in cells versus ones cleaved by recruiting ribonuclease effector proteins. Amir also developed a pipeline to use the binding data to predict 3D rna small molecule pockets in human rnas, a hard. problem
Transcriptome-Wide, Unbiased Profiling of Ribonuclease Targeting Chimeras | Journal of the American Chemical Society @disney_lab
@UFScripps @scrippsresearch #Transcriptome #Profiling #Ribonuclease #Chimeras pubs.acs.org/doi/10.1021/jac…
Raphael Isaac Benhamou retweeted
We updated our methods to profile small molecule-RNA interactions (started 10 yrs ago), evolving to cellular transcriptome-wide, unbiased approaches. As further advances occur, they will be available as a preprint and at our lab's homepage biorxiv.org/cgi/content/shor…
Raphael Isaac Benhamou retweeted
Heterobifunctional small molecules to modulate RNA function: Trends in Pharmacological Sciences …. Congratulations sandra and hamish (yuquan) and jess! cell.com/trends/pharmacologi…
Raphael Isaac Benhamou retweeted
Attention international postdocs:
Applications for the Azrieli International Postdoctoral Fellowship are now being accepted and are due by May 9!
The Azrieli International Postdoctoral Fellowship supports the best and brightest minds in their postdoctoral research in Israel, connecting them with world-class academics and leading researchers.
Please note that candidates are required to have an academic sponsor, who is a faculty member at an eligible Israeli academic institution.
@azrielifdn
Raphael Isaac Benhamou retweeted
BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Raphael Isaac Benhamou retweeted
A dream coming true: Thank you @ERC_Research for supporting my lab at @Hujimed! Come live the dream with us!
We are recruiting postdocs with Ephys/bioinformatics skills to unlock the molecular basis of anxiety and depression comorbidity. Please RT!
Exciting news for @HebrewU! @ERC_Research grants 16.7M euros to 10 scholars for their groundbreaking researches. #HebrewU leads with the highest grant success rate in Israel! Congratulations to the receivers! #ERCGrants #HebrewUniversity
shorturl.at/dhxXZ
Raphael Isaac Benhamou retweeted
grateful to contribute this paper in memory on the incomparable Richard Lerner, the leader of scripps - RIP Richard! DNA‐Encoded Libraries and Their Application to RNA - Yang - Israel Journal of Chemistry - Wiley Online Library onlinelibrary.wiley.com/doi/…
Raphael Isaac Benhamou retweeted
Congrats to team, J Bush @EricTWang, on platform to profile RNA binding small molecules transcriptome-wide. Study shows in Myotonic Dystrophy that augmenting binders as degraders can provide specificity beyond binder to improve disease defects. pubs.acs.org/doi/10.1021/acs…


















